PHASE 3 MULTI-CENTER RANDOMIZED STUDY TO COMPARE EFFICACY AND SAFETY OF ROMIDEPSIN CHOP (Ro-CHOP) VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMA
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Romidepsin (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Registrational; Therapeutic Use
- Acronyms Ro-CHOP
- 29 Jun 2017 This trial has been completed in Germany (end date: 10 May 2017).
- 04 Sep 2015 Planned End Date changed from 1 Jul 2022 to 1 Jul 2024 as reported by ClinicalTrials.gov record.
- 21 Sep 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2012-001580-68).